Corrigendum to: “Inhibition of NLRP3 alleviated chemotherapy-induced cognitive impairment in rats” [Neurosci. Lett. 2023 (793) 136975] (Neuroscience Letters (2023) 793, (S0304394022005365), (10.1016/j.neulet.2022.136975))

The authors regret that the published version of the above article contained an error in figure panel 3B that they did not identify during the proofing stage. Original figure panel 3B was a duplication of a figure panel (8A) from a paper published by some of the same authors (Zhao et al., Involvement of Toll Like Receptor 2 Signaling in Secondary Injury during Experimental Diffuse Axonal Injury in Rats, Mediators of Inflammation, 2017, PMC5331293). The corresponding author states that this was due to a lack of effective management of the raw data from previously published articles coupled with significant turnover among research team members. The corrected Figure 3 is shown below. The authors state that the correction does not change the scientific conclusions of the article in any way, and apologize for any inconvenience caused.[Formula